Zynerba Pharmaceuticals, Inc. EPS - Earnings per Share 2015-2023 | ZYNE
Zynerba Pharmaceuticals, Inc. eps - earnings per share from 2015 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Zynerba Pharmaceuticals, Inc. Annual EPS |
| 2022 |
$-0.82 |
| 2021 |
$-0.95 |
| 2020 |
$-1.90 |
| 2019 |
$-1.50 |
| 2018 |
$-2.61 |
| 2017 |
$-2.48 |
| 2016 |
$-2.58 |
| 2015 |
$-2.82 |
| 2014 |
$-6.44 |
| 2013 |
$-1.63 |
| Zynerba Pharmaceuticals, Inc. Quarterly EPS |
| 2023-06-30 |
$-0.21 |
| 2023-03-31 |
$-0.21 |
| 2022-12-31 |
$-0.17 |
| 2022-09-30 |
$-0.20 |
| 2022-06-30 |
$-0.24 |
| 2022-03-31 |
$-0.21 |
| 2021-12-31 |
$-0.24 |
| 2021-09-30 |
$-0.26 |
| 2021-06-30 |
$-0.25 |
| 2021-03-31 |
$-0.20 |
| 2020-12-31 |
$-0.28 |
| 2020-09-30 |
$-0.31 |
| 2020-06-30 |
$-0.78 |
| 2020-03-31 |
$-0.53 |
| 2019-12-31 |
$-0.45 |
| 2019-09-30 |
$-0.08 |
| 2019-06-30 |
$-0.50 |
| 2019-03-31 |
$-0.47 |
| 2018-12-31 |
$-0.34 |
| 2018-09-30 |
$-0.47 |
| 2018-06-30 |
$-0.89 |
| 2018-03-31 |
$-0.91 |
| 2017-12-31 |
$-0.61 |
| 2017-09-30 |
$-0.63 |
| 2017-06-30 |
$-0.64 |
| 2017-03-31 |
$-0.60 |
| 2016-12-31 |
$-0.72 |
| 2016-09-30 |
$-0.67 |
| 2016-06-30 |
$-0.70 |
| 2016-03-31 |
$-0.49 |
| 2015-12-31 |
$-0.01 |
| 2015-09-30 |
$-0.66 |
| 2015-06-30 |
$-1.12 |
| 2015-03-31 |
$-1.03 |
| 2014-12-31 |
$-0.84 |
| 2014-09-30 |
$-2.64 |
| 2014-06-30 |
$-2.29 |
| 2014-03-31 |
$-0.67 |
